Altimmune
Develops peptide-based therapeutics for obesity and liver diseases.
Company facts
- Founded
- 1997
- Employees
- 59
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ALT
- Subsidiaries
- Altimmune LLC, Altimmune UK Limited, Spitfire Pharma LLC, Altimmune AU Pty Limited
Open positions
Senior Manager, IT Engineering & Security
Senior Manager, IT Engineering & Security Altimmune (NASDAQ: ALT) is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's lead candidate,…
Sr. Staff Accountant
Senior Staff Accountant Altimmune (NASDAQ: ALT) is a late clinical-stag e biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's lead candidate, pemvidutide, is a unique…
Director, Pharmacovigilance Operations
Altimmune (NASDAQ: ALT) is a late clinical-stag e biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's lead candidate, pemvidutide, is a unique dual-action therapy…
Senior Director, Drug Substance Development
Altimmune (NASDAQ: ALT) is a late clinical-stag e biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's lead candidate, pemvidutide, is a unique dual-action therapy…